 |
 |
 |
 |
 |
 |
 |
||||
|
||||||||||
 Construction, Characterization and PathologyPolypeptide Growth Factors and Prostate CancerAndrogen Axis and Prostate CancerImmunotherapyPre-Clinical TrialsReviews |
1. Kaplan, PJ., Mohan, S., Cohen, P., Foster, B.A., and Greenberg, N.M. 1999. The insulin-like growth factor axis and prostate cancer: Lessons from TRAMP. Cancer Research 59:2203-2209. [PDF] 2. Foster, B.F, Kaplan, P.J. and Greenberg, N.M. 1999. Changes in the Expression of FGF-7, FGF-10 and a Novel FGFR1iiicF Splice Form Correlate with Prostate Cancer Progression in the TRAMP Model. Prostate Cancer and Prostatic Diseases 2:76-82. [PDF] 3. Foster, B.A., Kaplan, P.J. and Greenberg, N.M. 1999. Peptide Growth Factors and Prostate Cancer: New Models, New Opportunities. Cancer and Metastasis Reviews 17:317-324. [PDF] 4. Huss, W.J., Hanranhan, C., Barrios, R., Simons, J.W., and Greenberg, N.M. 2001. Angiogenesis and prostate cancer: Identification of a molecular progression switch. Cancer Research 61: 2736-2743.[PDF] 5. Huss, W.J., Barrios and Greenberg, N.M. 2003. Differential Expression of Specific FGF Ligand and Receptor Isoforms During Angiogenesis Associated With Prostate Cancer Progression. The Prostate 54: 8-16 [PDF] 6. Polnaszek, N., Kwabi-Addo, B., Peterson, L., Ozen, M., Greenberg, NM, Ortega, S., Basilico, C., and Ittmann, M. 2003. FGF2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Research 63: 5754-5760. [PDF] 7. Foster, B.A, Evangelou, A., Gingrich, J.R., DeMayo, F.J., and Greenberg, N.M. 2002. Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice. Differentiation 70: 624-632. [PDF] 8. Freeman, K.W., Gangula, R.D., Welm, B.E., Ozen, M., Foster, B.A., Rosen, J.M., Ittmann, M., Greenberg, N.M., and Spencer, D.M. 2003. Conditional activation of FGFR1, but not FGFR2, in prostate cancer cells, leads to increased OPN induction, ERK activation and in vivo proliferation. Cancer Research 63: 6237-6243.[PDF] 9. Freeman, K.W., Welm, B.E., Gangula, R.D., Rosen, J.M., Ittmann, M., Greenberg, N.M. and Spencer, D.M. 2003. Inducible prostate neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Research 63:8256-8263 [PDF] |
